Format
Sort by
Items per page

Send to

Choose Destination

Links from Gene

Items: 1 to 20 of 293

1.

CD10 inhibits cell motility but expression is associated with advanced stage disease in colorectal cancer.

Raposo TP, Comes MS, Idowu A, Agit B, Hassall J, Fadhil W, Nica R, Ecker R, Yao T, Ilyas M.

Exp Mol Pathol. 2018 Jun;104(3):190-198. doi: 10.1016/j.yexmp.2018.04.002. Epub 2018 Apr 11.

PMID:
29653092
2.

The antioxidant xanthorrhizol prevents amyloid-β-induced oxidative modification and inactivation of neprilysin.

Lim CS, Han JS.

Biosci Rep. 2018 Feb 2;38(1). pii: BSR20171611. doi: 10.1042/BSR20171611. Print 2018 Feb 28.

3.

Stromal CD10 expression in breast cancer correlates with tumor invasion and cancer stem cell phenotype.

Louhichi T, Saad H, Dhiab MB, Ziadi S, Trimeche M.

BMC Cancer. 2018 Jan 6;18(1):49. doi: 10.1186/s12885-017-3951-8.

4.

CD10 down expression in follicular lymphoma correlates with gastrointestinal lesion involving the stomach and large intestine.

Ohnishi N, Takata K, Miyata-Takata T, Sato Y, Tari A, Gion Y, Noujima-Harada M, Taniguchi K, Tabata T, Nagakita K, Omote S, Takahata H, Iwamuro M, Okada H, Maeda Y, Yanai H, Yoshino T.

Cancer Sci. 2016 Nov;107(11):1687-1695. doi: 10.1111/cas.13031. Epub 2016 Oct 14.

5.

Mutations in MME cause an autosomal-recessive Charcot-Marie-Tooth disease type 2.

Higuchi Y, Hashiguchi A, Yuan J, Yoshimura A, Mitsui J, Ishiura H, Tanaka M, Ishihara S, Tanabe H, Nozuma S, Okamoto Y, Matsuura E, Ohkubo R, Inamizu S, Shiraishi W, Yamasaki R, Ohyagi Y, Kira J, Oya Y, Yabe H, Nishikawa N, Tobisawa S, Matsuda N, Masuda M, Kugimoto C, Fukushima K, Yano S, Yoshimura J, Doi K, Nakagawa M, Morishita S, Tsuji S, Takashima H.

Ann Neurol. 2016 Apr;79(4):659-72. doi: 10.1002/ana.24612. Epub 2016 Mar 17.

6.

CD10-Equipped Melanoma Cells Acquire Highly Potent Tumorigenic Activity: A Plausible Explanation of Their Significance for a Poor Prognosis.

Oba J, Nakahara T, Hashimoto-Hachiya A, Liu M, Abe T, Hagihara A, Yokomizo T, Furue M.

PLoS One. 2016 Feb 16;11(2):e0149285. doi: 10.1371/journal.pone.0149285. eCollection 2016.

7.

CD10 expression in the neuroendocrine carcinoma component of endometrial mixed carcinoma: association with long survival.

Uehara K, Ikehara F, Tanabe Y, Nakazato I, Oshiro M, Inamine M, Kinjo T.

Diagn Pathol. 2016 Feb 1;11:16. doi: 10.1186/s13000-016-0468-4.

8.

Haematological profile of 21 patients with hairy cell leukaemia in a tertiary care centre of north India.

Gupta AK, Sachdeva MU, Ahluwalia J, Das R, Naseem S, Sharma P, Kumar N, Malhotra P, Varma N, Varma S.

Indian J Med Res. 2015 Oct;142(4):426-9. doi: 10.4103/0971-5916.169204.

9.

CD10 Immunohistochemical Expression in Apocrine Lesions of the Breast.

Kővári B, Báthori Á, Cserni G.

Pathobiology. 2015;82(6):259-63. doi: 10.1159/000440664. Epub 2015 Oct 20.

10.

Neprilysin Confers Genetic Susceptibility to Alzheimer's Disease in Han Chinese.

Wang HZ, Bi R, Zhang DF, Li GD, Ma XH, Fang Y, Li T, Zhang C, Yao YG.

Mol Neurobiol. 2016 Sep;53(7):4883-92. doi: 10.1007/s12035-015-9411-z. Epub 2015 Sep 11.

PMID:
26362309
11.

Tumoral CD10 expression correlates with high-grade histology and increases risk of recurrence in patients with stage I lung adenocarcinoma.

Kadota K, Buitrago D, Lee MC, Villena-Vargas J, Sima CS, Jones DR, Travis WD, Adusumilli PS.

Lung Cancer. 2015 Sep;89(3):329-36. doi: 10.1016/j.lungcan.2015.06.003. Epub 2015 Jun 15.

12.

CD10-positive mantle cell lymphoma: biologically distinct entity or an aberrant immunophenotype? Insight, through gene expression profile in a unique case series.

Akhter A, Mahe E, Street L, Pournazari P, Perizzolo M, Shabani-Rad MT, Stewart DA, Mansoor A.

J Clin Pathol. 2015 Oct;68(10):844-8. doi: 10.1136/jclinpath-2015-202955. Epub 2015 Jun 29.

PMID:
26124315
13.

Role of CD10 Immunohistochemical Expression in Predicting Aggressive Behavior of Phylloides Tumors.

Tariq MU, Haroon S, Kayani N.

Asian Pac J Cancer Prev. 2015;16(8):3147-52.

14.

Mucinous phenotype and CD10 expression of primary adenocarcinoma of the small intestine.

Kumagai R, Kohashi K, Takahashi S, Yamamoto H, Hirahashi M, Taguchi K, Nishiyama K, Oda Y.

World J Gastroenterol. 2015 Mar 7;21(9):2700-10. doi: 10.3748/wjg.v21.i9.2700.

15.

CD10 expression in 325 testicular germ cell tumours.

Fankhauser CD, Sulser T, Zhong Q, Barghorn A, Moch H, Bode PK.

J Clin Pathol. 2015 May;68(5):400-3. doi: 10.1136/jclinpath-2014-202806. Epub 2015 Feb 23. No abstract available. Erratum in: J Clin Pathol. 2015 Jul;68(7):e2.

PMID:
25713420
16.

Tumoral CD10 expression correlates with aggressive histology and prognosis in patients with malignant pleural mesothelioma.

Kadota K, Villena-Vargas J, Nitadori J, Sima CS, Jones DR, Travis WD, Adusumilli PS.

Ann Surg Oncol. 2015 Sep;22(9):3136-43. doi: 10.1245/s10434-015-4374-x. Epub 2015 Jan 22.

17.

CD10-a new prognostic stromal marker in breast carcinoma, its utility, limitations and role in breast cancer pathogenesis.

Jana SH, Jha BM, Patel C, Jana D, Agarwal A.

Indian J Pathol Microbiol. 2014 Oct-Dec;57(4):530-6. doi: 10.4103/0377-4929.142639.

18.

Meta-analysis of the association between two neprilysin gene polymorphisms and Alzheimer's disease.

Guo X, Tang P, Liu P, Liu Y, Hou C, Li R.

J Neurol Sci. 2014 Nov 15;346(1-2):6-10. doi: 10.1016/j.jns.2014.07.064. Epub 2014 Aug 7. Review.

PMID:
25125048
19.

CD10 as a novel marker of therapeutic resistance and cancer stem cells in head and neck squamous cell carcinoma.

Fukusumi T, Ishii H, Konno M, Yasui T, Nakahara S, Takenaka Y, Yamamoto Y, Nishikawa S, Kano Y, Ogawa H, Hasegawa S, Hamabe A, Haraguchi N, Doki Y, Mori M, Inohara H.

Br J Cancer. 2014 Jul 29;111(3):506-14. doi: 10.1038/bjc.2014.289. Epub 2014 May 29.

20.

A neuroprotective brain-penetrating endopeptidase fusion protein ameliorates Alzheimer disease pathology and restores neurogenesis.

Spencer B, Verma I, Desplats P, Morvinski D, Rockenstein E, Adame A, Masliah E.

J Biol Chem. 2014 Jun 20;289(25):17917-31. doi: 10.1074/jbc.M114.557439. Epub 2014 May 13.

Supplemental Content

Support Center